Hvsen Biotechnology Dividends and Buybacks
Dividend criteria checks 2/6
Hvsen Biotechnology is a dividend paying company with a current yield of 2.6%.
Key information
2.6%
Dividend yield
0.2%
Buyback Yield
| Total Shareholder Yield | 2.8% |
| Future Dividend Yield | 1.4% |
| Dividend Growth | 50.2% |
| Next dividend pay date | n/a |
| Ex dividend date | n/a |
| Dividend per share | CN¥0.270 |
| Payout ratio | -98% |
Recent dividend and buyback updates
Recent updates
Hvsen Biotechnology Co., Ltd. (SZSE:300871) Stock Catapults 26% Though Its Price And Business Still Lag The Industry
Nov 14
Hvsen Biotechnology Co., Ltd.'s (SZSE:300871) Share Price Boosted 25% But Its Business Prospects Need A Lift Too
Sep 30Hvsen Biotechnology Co., Ltd. (SZSE:300871) Shares Could Be 21% Below Their Intrinsic Value Estimate
Aug 21Take Care Before Jumping Onto Hvsen Biotechnology Co., Ltd. (SZSE:300871) Even Though It's 27% Cheaper
Jun 05Hvsen Biotechnology Co., Ltd. (SZSE:300871) Stocks Shoot Up 37% But Its P/E Still Looks Reasonable
Mar 29Stability and Growth of Payments
Fetching dividends data
Stable Dividend: Whilst dividend payments have been stable, 300871 has been paying a dividend for less than 10 years.
Growing Dividend: 300871 has only been paying a dividend for 3 years, and since then payments have fallen.
Dividend Yield vs Market
| Hvsen Biotechnology Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (300871) | 2.6% |
| Market Bottom 25% (CN) | 0.6% |
| Market Top 25% (CN) | 2.1% |
| Industry Average (Pharmaceuticals) | 1.8% |
| Analyst forecast (300871) (up to 3 years) | 1.4% |
Notable Dividend: 300871's dividend (2.6%) is higher than the bottom 25% of dividend payers in the CN market (0.55%).
High Dividend: 300871's dividend (2.6%) is in the top 25% of dividend payers in the CN market (2.15%)
Earnings Payout to Shareholders
Earnings Coverage: 300871 is paying a dividend but the company is unprofitable.
Cash Payout to Shareholders
Cash Flow Coverage: 300871 is paying a dividend but the company has no free cash flows.
Discover strong dividend paying companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/26 17:21 |
| End of Day Share Price | 2024/12/26 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Hvsen Biotechnology Co., Ltd. is covered by 2 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Jiarui Lu | Guosen Securities Co., Ltd. |
| Li Wu | Tianfeng Securities Brokerage Co., Ltd |